• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新一代钙通道阻滞剂时代的氨氯地平

Amlodipine in the Era of New Generation Calcium Channel Blockers.

作者信息

Tiwaskar Mangesh, Langote Amit, Kashyap Resham, Toppo Archana

机构信息

Consultant Physician and Diabetologist, Asian Heart Institute, Mumbai, Maharashtra.

Consultant Nephrologist and Transplant Physician, Apollo Hospital, Nerul, Navi Mumbai, Maharashtra.

出版信息

J Assoc Physicians India. 2018 Mar;66(3):64-9.

PMID:30341872
Abstract

Amlodipine is a classical drug with varied properties extending from control of blood pressure to as an antianginal and anti atherosclerotic agent. Amlodipine is a longer acting dihydropyridine calcium channel blocker, effective for 24 hours BP control and cause no BP variability. It is a powerful, well-tolerated, and safe antihypertensive agents that is widely used either alone or as a key component of combination therapy for hypertension. Its effective BP reduction has shown proven benefits in cardiovascular event reduction that is supported with strong evidences from large randomised controlled trials. Combination therapies of amlodipine with other agents eliciting renin-angiotensin-aldosterone system blockade (angiotensin II receptor blockers or renin inhibitors) have shown effective blood pressure-lowering strategies in CV risk reduction and progression of renal disease. Novel type of calcium channel blockers have been developed which have additional properties of blocking T and N subtypes of calcium channels and apart from their class effects they exerts specific action on heart rate and renin aldosterone system. They are considered to be more renoprotective due to this additional properties. Amlodipine is most potent and longer acting agent compared to the newer CCBs, its effectiveness in BP lowering still makes it the agent of choice among all the CCBs.

摘要

氨氯地平是一种经典药物,具有多种特性,从控制血压到作为抗心绞痛和抗动脉粥样硬化药物。氨氯地平是一种作用时间更长的二氢吡啶类钙通道阻滞剂,对血压控制有效24小时,且不会引起血压波动。它是一种强效、耐受性良好且安全的抗高血压药物,广泛单独使用或作为高血压联合治疗的关键组成部分。其有效的血压降低已在减少心血管事件方面显示出已证实的益处,这得到了大型随机对照试验的有力证据支持。氨氯地平与其他引起肾素-血管紧张素-醛固酮系统阻断的药物(血管紧张素II受体阻滞剂或肾素抑制剂)的联合治疗已显示出在降低心血管风险和延缓肾脏疾病进展方面有效的降压策略。已经开发出新型钙通道阻滞剂,它们具有阻断钙通道T和N亚型的额外特性,除了其类效应外,还对心率和肾素醛固酮系统发挥特定作用。由于这种额外特性,它们被认为具有更强的肾脏保护作用。与新型CCB相比,氨氯地平是最有效的且作用时间更长的药物,其在降低血压方面的有效性仍然使其成为所有CCB中的首选药物。

相似文献

1
Amlodipine in the Era of New Generation Calcium Channel Blockers.新一代钙通道阻滞剂时代的氨氯地平
J Assoc Physicians India. 2018 Mar;66(3):64-9.
2
Disparate effects of angiotensin II antagonists and calcium channel blockers on albuminuria in experimental diabetes and hypertension: potential role of nephrin.血管紧张素II拮抗剂和钙通道阻滞剂对实验性糖尿病和高血压患者蛋白尿的不同影响:nephrin的潜在作用
J Hypertens. 2003 Jan;21(1):209-16. doi: 10.1097/00004872-200301000-00031.
3
Calcium channel blockers, either amlodipine or mibefradil, ameliorate renal injury in experimental diabetes.钙通道阻滞剂,无论是氨氯地平还是米贝拉地尔,都能改善实验性糖尿病中的肾损伤。
Kidney Int. 2004 Sep;66(3):1090-8. doi: 10.1111/j.1523-1755.2004.00859.x.
4
Amlodipine and loop diuretics as the second anti-hypertensive medication for the treatment of hypertension with chronic kidney diseases.氨氯地平和噻嗪类利尿剂作为二线抗高血压药物治疗伴有慢性肾脏病的高血压。
Clin Exp Hypertens. 2011;33(4):210-5. doi: 10.3109/10641963.2011.583965.
5
Combination therapy of angiotensin II receptor blocker and calcium channel blocker exerts pleiotropic therapeutic effects in addition to blood pressure lowering: amlodipine and candesartan trial in Yokohama (ACTY).血管紧张素 II 受体阻滞剂和钙通道阻滞剂联合治疗除了降压之外还具有多种治疗作用:横滨海湾临床试验(ACTY)中的氨氯地平和坎地沙坦。
Clin Exp Hypertens. 2012;34(4):249-57. doi: 10.3109/10641963.2012.681081. Epub 2012 May 9.
6
HYT-hypertension in Turkey: a cross-sectional survey on blood pressure control with calcium channel blockers alone or combined with other antihypertensive drugs.土耳其的HYT高血压:关于单独使用钙通道阻滞剂或与其他抗高血压药物联合使用时血压控制情况的横断面调查
High Blood Press Cardiovasc Prev. 2015 Jun;22(2):165-72. doi: 10.1007/s40292-015-0091-6. Epub 2015 Apr 22.
7
Amlodipine and atorvastatin in atherosclerosis: a review of the potential of combination therapy.氨氯地平和阿托伐他汀治疗动脉粥样硬化:联合治疗潜力的综述
Expert Opin Pharmacother. 2004 Feb;5(2):459-68. doi: 10.1517/14656566.5.2.459.
8
Combinations of inhibitors of the renin-angiotensin system with calcium channel blockers for the treatment of hypertension: focus on perindopril/amlodipine.血管紧张素转化酶抑制剂与钙通道阻滞剂联合治疗高血压:以培哚普利/氨氯地平为例。
Curr Med Res Opin. 2010 Sep;26(9):2263-76. doi: 10.1185/03007995.2010.510925.
9
A new-generation N/L-type calcium channel blocker leads to less activation of the renin-angiotensin system compared with conventional L type calcium channel blocker.一种新一代的 N/L 型钙通道阻滞剂与传统的 L 型钙通道阻滞剂相比,较少激活肾素-血管紧张素系统。
J Hypertens. 2010 Oct;28(10):2156-60. doi: 10.1097/HJH.0b013e32833d01dd.
10
Effects of strict blood pressure control by a long-acting calcium channel blocker on brain natriuretic peptide and urinary albumin excretion rate in Japanese hypertensive patients.长效钙通道阻滞剂严格控制血压对日本高血压患者脑钠肽及尿白蛋白排泄率的影响
Hypertens Res. 2008 May;31(5):887-96. doi: 10.1291/hypres.31.887.

引用本文的文献

1
Amlodipine Attenuates Carrageenan-induced Oxidative Stress Targeting Transsynaptic 
Neuronal Damage by Promoting Survival of 
Retinal Ganglion Cells in Adult Zebrafish 
(.氨氯地平通过促进成年斑马鱼视网膜神经节细胞的存活减轻角叉菜胶诱导的氧化应激靶向跨突触神经元损伤
Ann Neurosci. 2024 Jun 6:09727531241246671. doi: 10.1177/09727531241246671.
2
Efficacy and safety of single-pill amlodipine/losartan versus losartan in patients with inadequately controlled hypertension after losartan treatment: a multicenter, double-blind, randomized phase III clinical trial.氨氯地平/氯沙坦单片复方制剂与氯沙坦用于氯沙坦治疗后血压控制不佳患者的疗效和安全性:一项多中心、双盲、随机III期临床试验
Front Cardiovasc Med. 2023 Jun 19;10:1177166. doi: 10.3389/fcvm.2023.1177166. eCollection 2023.
3
Reno protective role of amlodipine in patients with hypertensive chronic kidney disease.氨氯地平对高血压慢性肾病患者的肾脏保护作用。
World J Nephrol. 2022 May 25;11(3):86-95. doi: 10.5527/wjn.v11.i3.86.
4
Effects of different enantiomers of amlodipine on lipid profiles and vasomotor factors in atherosclerotic rabbits.氨氯地平不同对映体对动脉粥样硬化兔血脂谱和血管舒缩因子的影响。
Open Life Sci. 2021 Sep 6;16(1):899-908. doi: 10.1515/biol-2021-0077. eCollection 2021.
5
Effect of Amlodipine in Stroke and Myocardial infarction: A Systematic Review and Meta-analysis.氨氯地平对中风和心肌梗死的影响:一项系统评价和荟萃分析。
Cardiol Ther. 2021 Dec;10(2):429-444. doi: 10.1007/s40119-021-00239-1. Epub 2021 Sep 4.
6
Effectiveness and Effect on Renal Parameters of Amlodipine vs. Other Dihydropyridine Calcium Channel Blockers in Patients with Essential Hypertension: Retrospective Observational Study Based on Real-World Evidence from Electronic Medical Records.氨氯地平与其他二氢吡啶类钙通道阻滞剂治疗原发性高血压患者的疗效及对肾脏参数的影响:基于电子病历真实世界证据的回顾性观察研究
Cardiol Ther. 2021 Dec;10(2):465-480. doi: 10.1007/s40119-021-00224-8. Epub 2021 Jun 11.
7
Pharmacokinetic interactions of esaxerenone with amlodipine and digoxin in healthy Japanese subjects.在健康的日本受试者中,依普利酮与氨氯地平和地高辛的药代动力学相互作用。
BMC Pharmacol Toxicol. 2020 Jul 29;21(1):55. doi: 10.1186/s40360-020-00423-4.
8
Antioxidant, Anti-inflammatory and Neuroprotective Profiles of Novel 1,4-Dihydropyridine Derivatives for the Treatment of Alzheimer's Disease.新型1,4 - 二氢吡啶衍生物治疗阿尔茨海默病的抗氧化、抗炎和神经保护特性
Antioxidants (Basel). 2020 Jul 22;9(8):650. doi: 10.3390/antiox9080650.